Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.
about
Polypoidal Choroidal Vasculopathy in AsiansIntravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study.High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian populationRanibizumab for the treatment of wet AMD: a summary of real-world studies.Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy.Association of ARMS2 genotype with response to anti-vascular endothelial growth factor treatment in polypoidal choroidal vasculopathy.Prevalence and treatment patterns of ranibizumab and photodynamic therapy in a tertiary care setting in Malaysia.Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan.Association of Genes in the High-Density Lipoprotein Metabolic Pathway with Polypoidal Choroidal Vasculopathy in Asian Population: A Systematic Review and Meta-Analysis.Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen.Polypoidal Choroidal Vasculopathy.
P2860
Q26799548-37A7EDFE-E8E4-4DF9-9223-8B364D56DCEAQ34551927-5FC695D5-9704-422B-BA5A-427E4630EABAQ34818910-B230BFBF-1AA4-49FF-9C33-8E564919402EQ36750280-C19E80B6-0686-4E3A-81B4-E5E2C28D9946Q38592591-1FCFBDDD-1EBE-4016-8AAE-8DB83EFAA2A8Q41968267-AB65A42F-C7D7-4AF4-A6C5-8F3CD0B2EAE4Q47105965-79BD41C0-A7F8-4E13-990A-6DE343FBF331Q47139871-A84FBB29-4766-4756-856B-D279CA8BD55FQ50238082-93A95ABC-3C9D-46DD-8741-0D9F017CC6A3Q55009931-BF62D408-CCDB-469C-ADF9-632AEA94E4C9Q55420523-DC51DB77-9D74-4E4E-AD51-5754B00E3286Q55431176-B8155EA5-EA52-4706-AE20-FCAE699A8E8EQ55714679-AA426801-63BE-4DAC-8CA4-B1F07DFFBE22
P2860
Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@ast
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@en
Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration
@nl
type
label
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@ast
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@en
Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration
@nl
prefLabel
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@ast
Effectiveness of intravitreal ...... pathy over a 1 year follow-up.
@en
Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration
@nl
P2093
P2860
P356
P1433
P1476
Effectiveness of intravitreal ...... opathy over a 1 year follow-up
@en
P2093
Akira Negi
Shigeru Honda
Wataru Matsumiya
Yasutomo Tsukahara
P2860
P2888
P356
10.1186/1471-2415-13-10
P577
2013-04-04T00:00:00Z
P5875
P6179
1045361136